Skip to Main Content

Author Details

Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
1995
420
70
PMIDPaper TitleJournal TitlePublished Year
36729801Inflammatory Breast Cancer: Understanding the Patient Experience.Cancer Nurs2024
36757813Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer.JCI Insight2023
37961619Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted Modeling.Res Sq2023
37547448PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.Ther Adv Med Oncol2023
37146584Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.Cell Stem Cell2023
37043123Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.Invest New Drugs2023
36979714Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.Biomedicines2023
37444385Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial.Cancers (Basel)2023
37377604Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.Cancer Res Commun2023
37437342The immunogram of inflammatory breast cancer.Cancer Treat Rev2023
37398275Inflammatory breast cancer biomarker identification by simultaneous TGIRT-seq profiling of coding and non-coding RNAs in tumors and blood.medRxiv2023
36717329Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target.Breast2023
36900406Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients.Cancers (Basel)2023
34250544Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment.J Natl Cancer Inst2022
35507014Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.Clin Cancer Res2022
35379811Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling.Nat Commun2022
35834145Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.Ann Surg Oncol2022
35793453An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates.Mol Cancer Ther2022
35574694Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape.Expert Opin Ther Targets2022
35854031Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.Ann Surg Oncol2022
35663226Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis.Mol Ther Oncolytics2022
36525493EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.Sci Adv2022
36104531ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.Ann Surg Oncol2022
36358657A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System.Cancers (Basel)2022
36127293Interview with Prof. Naoto T. Ueno, an inflammatory breast cancer expert.Chin Clin Oncol2022
36030283ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.Ann Surg Oncol2022
35042871Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC.NPJ Breast Cancer2022
35267631Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.Cancers (Basel)2022
35169199A gene signature consisting of ubiquitin ligases and deubiquitinating enzymes of SKP2 is associated with clinical outcome in breast cancer.Sci Rep2022
35294223Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.JCO Precis Oncol2022
34893874NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.J Natl Cancer Inst2022
33323457Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent Apoptosis.Mol Cancer Ther2021
33492987Optimal Supportive Care for Patients With Metastatic Breast Cancer According to Their Disease Progression Phase.JCO Oncol Pract2021
33514514Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer.Cancer Res2021
33902690Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.Genome Med2021
33736924High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.Ann Oncol2021
33482584Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope.Bioorg Med Chem2021
33814103Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy.Semin Ultrasound CT MR2021
33861773Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.PLoS One2021
33557032The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy.Cancers (Basel)2021
35059078Advances in Oncology in US and Japan: Focusing on Cancer and Infectious Diseases.World J Oncol2021
34930010"Why and What" for the optimal management of inflammatory breast cancer.Chin Clin Oncol2021
34638323A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer.Cancers (Basel)2021
34680527ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells.Biomedicines2021
34131830A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.Breast Cancer Res Treat2021
34327874Inflammatory breast cancer appearance at presentation is associated with overall survival.Cancer Med2021
34104544Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors.Oncoimmunology2021
34071219Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer.Cancers (Basel)2021
34125346Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.Ann Surg Oncol2021
34241740Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.Breast Cancer Res Treat2021
  • 1 - 50 of 420

Recommended Authors

Chiara Corti
University of Milano
Career Start Year 2017
Number of shared co-authors 3
Kevin Punie
Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 15
Konstantinos Tryfonidis
Merck & Co., Inc.
Career Start Year 2011
Number of shared co-authors 7
Yin Liu
Fudan University Shanghai Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 7
Carmen Criscitiello
University of Milano
Career Start Year 2008
Number of shared co-authors 4
Naoto Kondo
Nagoya City University Graduate School of Medical Sciences
Career Start Year 2006
Number of shared co-authors 2
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 10
Sara M Tolaney
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 10
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 14
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Aditya Bardia
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 10
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 8
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 2
Peter A Fasching
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 11
Matthew P Goetz
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 10
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 13
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Career Start Year 2000
Number of shared co-authors 17
Ingrid A Mayer
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 13
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 11
Steven J Isakoff
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 5
Carolien P Schr??der
University of Groningen, University Medical Center Groningen
Career Start Year 1995
Number of shared co-authors 4
Linda T Vahdat
Dartmouth Cancer Center
Career Start Year 1993
Number of shared co-authors 8
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 3
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 11
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 4
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 4
Gottfried E Konecny
David Geffen School of Medicine at University of California Los Angeles
Career Start Year 1984
Number of shared co-authors 4
Larry Norton
Memorial Sloan Kettering Cancer Center
Career Start Year 1976
Number of shared co-authors 14
Dennis J Slamon
David Geffen School of Medicine at university of california los angeles
Career Start Year 1973
Number of shared co-authors 11

Collaborators

Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers 103
James M Reuben
The University of Texas MD Anderson Cancer Center
Co-authored papers 67
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers 53
Bora Lim
The University of Texas MD Anderson Cancer Center
Co-authored papers 45
Yu Shen
Co-authored papers 29
Thomas A Buchholz
Co-authored papers 23
Michele Donato
Co-authored papers 21
William F Symmans
Co-authored papers 20
Lajos Pusztai
Co-authored papers 16
Mien-Chie Hung
Co-authored papers 15
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 13
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 13
Simona F Shaitelman
University of Texas MD Anderson Cancer Center
Co-authored papers 9
Daniel Birnbaum
Co-authored papers 9
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 9
Wei Yang
Co-authored papers 9
Angela Alexander
University of Texas MD Anderson Cancer Center
Co-authored papers 8
Yuan Qi
Co-authored papers 8
Eleni Andreopoulou
New York Presbyterian Hospital
Co-authored papers 7
Fredika M Robertson
University of Texas M.D. Anderson Cancer Center
Co-authored papers 7
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Koen van Besien
University Hospitals of Cleveland
Co-authored papers 7
Arvind Rao
University of Michigan-Ann Arbor
Co-authored papers 7
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Chen Hu
Johns Hopkins University School of Medicine
Co-authored papers 6
Sharon H Giordano
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Peter Kuhn
University of Tubingen
Co-authored papers 5
Sriram Yennu
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Anand Kolatkar
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 4
Release 1.2